Figure 4From: Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinoma Chest CT showing disease response and a 50% left-sided pneumothorax. Staging CT scan following 4 weeks of treatment showing disease response and a 50% left-sided pneumothorax on ‘lung windows’.Back to article page